← FDA Drug Approvals (Drugs@FDA)

TIGECYCLINE

NDA · New Drug Application · Sponsor: FRESENIUS KABI USA · Approved 2016-12-01

Drug application

FDA Application #

NDA205645

Application type

New Drug Application

Brand name

TIGECYCLINE

Generic name

TIGECYCLINE

Active ingredients

TIGECYCLINE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

FRESENIUS KABI USA

Manufacturer

Fresenius Kabi USA, LLC

First approval

2016-12-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown